✦ LIBER ✦

Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study

✍ Scribed by Dreux, Sophie; Nguyen, Claire; Czerkiewicz, Isabelle; Schmitz, Thomas; Azria, Elie; Fouré, Marc-Antoine; Muller, Françoise

Book ID: 122946218
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 226 KB
Volume: 208
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2013.01.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maternal serum markers. Estimation of th

Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study

✍ Giuliana Mancini; Marco Perona; Daniela Dall'Amico; Carla Bollati; Fulvia Albano 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 430 KB

Screening for trisomy 18 by fetal nuchal

Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β -hCG and PAPP-A at 10–14 weeks of gestation

✍ Natasha Tul; Kevin Spencer; Penelope Noble; Christine Chan; Kypros Nicolaides 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

In a study of 50 cases of trisomy 18 compared with 947 controls we have found the median multiple of the median (MoM) of maternal serum free human chorionic gonadotrophin to be significantly decreased (0.281 MoM) in samples collected between the 10th and 14th week of gestation. Similarly, maternal s

Screening for Down syndrome using first-

Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study

✍ Dr F. Audibert; M. Dommergues; C. Benattar; J. Taieb; J.-C. Thalabard; R. Frydma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Triple marker (AFP, uE3,hCG) versus AFP

Triple marker (AFP, uE3,hCG) versus AFP plus free-beta in second trimester maternal serum screening for down syndrome: A prospective comparison study

✍ L.H. Kellner; Z. Weiner; R.R. Weiss; M. Neuer; G. Martin; M. Mueenuddin; A. Bomb 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 130 KB

P10.19: Down's syndrome screening at mat

P10.19: Down's syndrome screening at maternal age ≥ 35 years with non-intervention examination at 11 − 13 + 6 weeks of gestation—a preliminary report

✍ I. O. Marsis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Triple marker (α-fetoprotein, unconjugat

Triple marker (α-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus α-fetoprotein plus free-β subunit in second-trimester maternal serum screening for fetal Down syndrome: A prospective comparison study

✍ Leonard H. Kellner; Zeev Weiner; Robert R. Weiss; Marsha Neuer; Gregory M. Marti 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 391 KB